Syracuse University

SURFACE
Syracuse University Honors Program Capstone
Projects

Syracuse University Honors Program Capstone
Projects

Spring 5-2017

Studies towards the synthesis of (-)-centrolobine via the carbonyl
ene reaction of exocyclic enol ethers
Brianna Shores
Syracuse University

Follow this and additional works at: https://surface.syr.edu/honors_capstone
Part of the Chemistry Commons

Recommended Citation
Shores, Brianna, "Studies towards the synthesis of (-)-centrolobine via the carbonyl ene reaction of
exocyclic enol ethers" (2017). Syracuse University Honors Program Capstone Projects. 1019.
https://surface.syr.edu/honors_capstone/1019

This Honors Capstone Project is brought to you for free and open access by the Syracuse University Honors Program
Capstone Projects at SURFACE. It has been accepted for inclusion in Syracuse University Honors Program Capstone
Projects by an authorized administrator of SURFACE. For more information, please contact surface@syr.edu.

Studies Towards the Synthesis of (-)-Centrolobine via the Carbonyl Ene Reaction of Exocyclic
Enol Ethers

A Capstone Project Submitted in Partial Fulfillment of the
Requirements of the Renée Crown University Honors Program at
Syracuse University

Brianna Shores

Candidate for Bachelor of Science
and Renée Crown University Honors
Spring 2017

Honors Capstone Project in Chemistry
Capstone Project Advisor: _______________________
Dr. Nancy I. Totah
Capstone Project Reader: _______________________
Dr. James Kallmerten
Honors Director:

_______________________
Chris Johnson, Interim Director

© (Brianna Shores 2017)

ii

Abstract

The goal of this study is the synthesis of centrolobine 7, a naturally-occuring compound
that exhibits anti-parasitic and anti-inflammatory activity.
The strategy is to utilize the carbonyl ene reaction to form the 2,6-disubstituted
framework of centrolobine 7 from exocyclic enol ether 110 and aldehyde 111. Exocyclic enol
ether 110 would be synthesized via literature procedures starting from commercially available
glutaric anhydride 11 and anisole 114.
The work completed to date optimizing the following reactions: Friedel-Crafts acylation
of glutaric anhydride 11 and anisole 114, the reduction of alcohol 116, and cyclization of alcohol
116 to lactone 112. To form exocyclic enol ether 110 from lactone 112. Difficulties with
isomerization to the corresponding endocyclic enol ether 126 prevented an optimized
converstion of lactone 112 to exocyclic enol ether 110. The ene reaction of exocyclic enol ether
110 and aldehyde 111 showed some promise. Significant progress was made towards the
synthesis of centrolobine 7 via the carbonyl ene reaction, and can be completed in future studies.
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Executive Summary

One of the main focuses of organic chemistry is synthesis. Synthesis involves developing
a series of reactions from commercially available starting materials to build a more complex
molecule. The goal of a synthesis is to build a compound that may not be easily obtained. These
compounds can be natural products; polymers; and biomolecules including peptides,
carbohydrates, and nucleic acids. An ideal organic synthetis has few steps, a high overall yield,
and produces minimal waste.
Natural products are of particular interest in organic synthesis. They are naturally
occurring compounds that can be obtained from any living organism. Organic chemists
synthesize these compounds because they often have a unique arrangement of atoms that require
new chemistry to build. Additionally, novel structures presented by natural compounds represent
new leads toward drug development.
To develop new pharmaceutical products, organic chemists need to be able to synthesize
target compounds quickly and efficiently so that they can be tested for potential biological
activity. Analogs of natural products, molecules with the same general structure but different
substituents, often display a similar or enhanced bioactivity. An efficient synthesis of a natural
product can be adapted to the preparation of analogs with useful pharmocology.
The target of this study is centrolobine. Centrolobine 7 displays antiparasitic and
antinflammatory properties. Centrolobine 7 has a simple overall structure consisting of a central
tetrahydropyran subunit with substituents on the C2 and C6 positions. It is a useful target to
demonstrate new techniques to build a tetrahydropyran structure in a molecule. Other
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biologically active molecules possess this tetrahydrofuranyl system, and strategies for
construction of centrolobine 7 may be applicable to the synthesis of other bioactive compounds.
The goal of this research was to demonstrate the use of the ene reaction of exocyclic
enroll ethers to synthesize centrolobine. The ene reaction is the key step in this synthesis, which
would form the 2,6-disubstituted framework of centrolobine from an exocyclic enol ether and a
carbonyl compound. The substituents on the exocyclic enol ether and the carbonyl compound
can easily be changed, allowing access to new analogs of centrolobine.
To develop the synthesis of centrolobine using the ene reaction of exocyclic enol ethers, a
retrosynthetic analysis of centrolobine was conducted (Scheme i). Retrosynthetic analyses are
commonly employed in organic chemistry to determine how a complex molecule can be
produced by working backwards from the desired product. It was anticipated that alcohol 109
can be transformed into centrolobine 7 by simultaneous reduction of the double bond and
hydroxyl group, followed by cleavage of the protecting group on the phenol component. Alcohol
109 would result from the ene reaction of exocyclic enol ether 110 and aldehyde 111. Exocyclic
enol ether 110 can be made from lactone 112 via the Petasis reagent, whilc lactone 112 would be
synthesized by the cyclization of carboxylic acid 113. The Friedel-Crafts acylation of glutaric
anhydride 11 and anisole 114 will produce carboxylic acid 113.

v

Scheme i:

Modifications of the starting materials and components of the ene reaction will extend
this synthesis to the preparation of centrolobine analogs. Optimization of each reaction will result
in high yields for each product. The successful synthesis of centrolobine 7 will demonstrate the
feasibility of the ene reaction of exocyclic enol ethers as an efficient route to molecules
containing tetrahydropyran structures.
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Chapter 1

Introduction
I. Importance of Tetrahydropyrans
One major branch of organic chemistry is the development of new reactions and
strategies of new compounds. Of particular interest are naturally occurring compounds, targets
that are complex and often found in small quantities from a natural source such as tree bark,
bacteria, or a marine species. 1 Synthesizing a natural product often results in the discovery or
application of new reactions because these molecules have unique arrangements. Furthermore,
natural products are the most successful source of new drug leads. Researchers who are
interested in developing new drugs do not have the time nor the resources to invest to
synthesizing these compounds from scratch. Rather, they turn to academic groups to research
efficient syntheses for natural compounds of interest. 2
To develop new drugs, organic chemists need to synthesize natural compounds quickly
so they can be tested for biological activity. Additionally, most drugs are developed from analogs
of natural products. Developing a flexible synthesis, which allows for adjustment of reagents to
produce these analogs, further leads to new drug discovery. 3
A common substructure of natural products is the oxygen heterocycle tetrahydropyran 1.
Molecules containing this subunit can display antifungal, anticancer, and antibacterial

1

Nicolaou, K. C. P. Roy. Soc. Lond. A. Mat. 2014, 470, 20130690.
Harvey, A. Rev. Salud Anim. 2009, 31, 8.
3
Karpf, M.; Kunisuke Izawa, K. I.; Konoike, T. In Pharmaceutical Process Chemistry; Shioiri, T., Ed.; Wiley,
2010.
2

2
properties. 4. Examples of biologically active natural products with the tetrahydropyran structure
1 are shown below in Figure 1.
Figure 1:

Ambruticin S 2 is a naturally occurring antifungal isolated from the myxobacterium
Polyangium cellulosum. 5 The structure and absolute stereochemistry of Ambruticin S 2 was

4

Cossy, J.; Guérinot, A. Advances in Heterocyclic Chemistry, 2016, 119, 107–142. DOI:
10.1016/bs.aihch.2016.03.002
5
(a) Connor, D. T.; Greenough, R. C.; von Strandtmann, M. J. Org. Chem. 1977, 42, 3664. (b) Ringel, S. M.;
Greenough, R. C.; Roemer, S.; Connor, D.; Gutt, A. L.; Blair, B.; Kanter, G.; von Strandmann, M. J. Antibiot. 1977,
371.

3
determined using single crystal X-ray of degradation products. 6 Ambruticin S 2 and its analogs
possess antifungal activity against Aspergillus flavus, Blastomyces dermatitidis, Coccidioides
immitis, and Hansenula anomala that derives from interference with the osmoregulatory system
of the fungi. 7 It is suggested that the ambruticins induce one of the structures involved in glycol
signaling by targeting the histidine kinase hik1. 8
Aspergillide B 3 is a secondary metabolite isolated from the marine fungus Aspergillus
ostianus strain 01F313. 9 The structure of compound 3 was determined using IR spectroscopy and
1D and 2D 1H and 13C NMR.9 This compound displays cytotoxic activity towards the mouse
lymphatic leukemia cell with an LD50 value of 71.0 μg mL-1.9 Its most recent synthesis was
reported by Loh who synthesized aspergillide B and its analog aspergillide A, where all the
carbon atoms in both compounds originated from plant matter. 10
Morinol A 4 is a compound isolated by Kusumi from the traditional Chinese medicinal
plant Morina chinensis in 1999. The structure of compound 4 was determined via 2D NMR (1H1

H COSY, HSQC, HMBC, and NOESY) and HRFABMS spectroscopy. 11 In the same study, the

bioactivity of Morinol A 4 on cytokine production was investigated. Morinol A 4 displayed a
62% inhibition of the cytokine IL-2. Another study by Yamauchi reported that Morinol A 4

6

(a) Barnes, N. J.; Davidson, A. H.; Hughes, L. R.; Procter, G.; Rajcoomar, V. Tetrahedron Lett. 1981, 22, 1751. (b)
Just, G.; Poitvin, P. Can. J. Chem. 1980, 58, 2173.
7
Hanessian, S.; Focken, T.; Mi, X.; Oza, R.; Chen, B.; Ritson, D.; Beaudegnies, R. J. Org. Chem. Soc. 2010, 75,
5601. DOI: 10.1021/jo100956v
8
(a) Wesolowski, J.; Hassan, R. Y. A.; Reinhardt, K.; Hodde, S.; Bilitewski, U. J. Appl. Microbiol. 2010, 108, 462.
(b) Dongo, A.; Bataille-Simoneau, N.; Campion, C.; Guillemette, T.; Hamon, B.; Iacomi-Vasilescu, B.; Katz, L.;
Simoneau, P. Appl. Environ. Microbiol. 2009, 75, 127. (c) Vetcher, L.; Menzella, H. G.; Kudo, T.; Motoyama, T.;
Katz, L. Antimicrob. Agents Chemother. 2007, 51, 3734. (d) Knauth, P.; Reichenbach, H. J. Antibiot. 2000, 53,
1182.
9
K. Kito, R. Ookura, S. Yoshida, M. Namikoshi, T. Ooi and T. Kusumi. Org. Lett. 2008, 10, 225. DOI:
10.1021/ol702598q
10
Koh, P.-F.; Loh, T.-P. Green Chem. 2015, 17, 3746. DOI: 10.1039/C5GC00900F
11
Su, B.-N.; Takaishi, Y.; Kusumi, T. Tetrahedron 1999, 55, 14571. DOI: 10.1016/s0040-4020(99)00933-3
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displayed an IC50 value of 23.8 μM against HeLa cells and an IC50 value of 34.7 μM against HL60 cells. 12
Indanomycin 5 is an antibiotic isolated from the bacterium Streptomyces antibioticus.
The compound was first isolated in 1978 by ethyl acetate extraction of the fermentation broth by
Westley. 13 Indanomycin 5 acts as a K+ carrier in the mitochondrial membrane but is also capable
of transporting di- and trivalent metal cations within the bacterium. 14 Indanomycin 5 is active in
vitro against Gram-positive bacteria with a wide range activity against several strains including
Pseudomonas aeruginosa ATCC 8709 and Sarcina lutea ATCC 9341. 15 The structure of
compound 5 and absolute configuration were determined by single crystal X-ray analysis.13a
The antitumor compound GEX1A was isolated from the bacterium Streptomyces
chromofusces in 1992. 16 The structure of compound 6 was established using IR, 1H NMR, 13C
NMR, UV, and HRFAB-MS spectroscopy. Originally known as herboxidiene, this compound
displays selective herbicidal activity against different weed strains. Later studies showed that
GEX1A displayed antitumor activity against several human tumor cell lines including
epidermoid carcinoma A431 cells, lung carcinoma A549 cells, and colon carcinoma DLD-1 cells
with IC50 values of 0.0037 μM, 0.021 μM, and 0.051 μM respectively. 17 A later study showed

12

Yamauchi, S.; Kawahara, S.; Wukirsari, T.; Nishiwaki, H.; Nishi, K.; Sugahara, T.; Akiyama, K.; Kishida,
T. Bioorg. Med. Chem. Lett. 2013, 23, 4923. DOI: 10.1016/j.bmcl.2013.06.067
13
(a) Westley, J. W.; Evans, R. H., Jr.; Liu, C.-M.; Hermann, T.; Blount, J. F. J. Am. Chem. Soc. 1978, 100, 6784.
(b) Westley, J. W.; Liu, C.-M. U.S. Patent 4100171, 1978.
14
(a) Westley, J. W. Adv. Appl. Microbiol. 1977, 22, 177. (b) Pressman, B. C. Annu. Rev. Biochem. 1976, 45, 501.
15
Liu, C.-M.; Hermann, T. E.; Liu, M.; Bull, D. N.; Palleroni, N. J.; Prosser, B. L. T.; Westley, O. W.; Miller, P.
A. J. Antibiot. 1979, 32, 95. DOI: 10.7164/antibiotics.32.95
16
Miller-Wideman, M.; Makkar, N.; Tran, M.; Isaac, B.; Biest, N.; Stonard, R. J. Antibiot. 1992, 45, 914. DOI:
10.7164/antibiotics.45.914
17
Sakai, Y.; Yoshida, T.; Ochiai, K.; Uosaki, Y.; Saitoh, Y.; Tanaka, F.; Akiyama, T.; Akinaga, S.; Mizukami, T. J.
Antiobiot. 2002, 55, 855. DOI: 10.7164/antibiotics.55.855
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that GEX1A could potentially serve as a splicing inhibitor because it binds to a protein
responsible for pre-mRNA splicing. 18
Centrolobine 7 was isolated from the heartwood of Centrolobium robustum tree in the
Amazon in 1964 and from the stem of Brosinum potabile. 19 The structure of centrolobine 7 was
determined by COSEY and NOESY 2D NMR experiments. At this time, the relative
configuration of the compound was established by De Albuquerque based on an empirical model
by Brewster however its absolute configuration was unknown. 20 This compound displays
antiparasitic activity against Leishmania amazonensis promastigotes, a parasite that causes the
disease leishmaniasis, a major health problem in Brazil. 21 Centrolobine 7 also displays some
anti-inflammatory activity.19c
These are only a few of the many natural products containing tetrahydropyrans that
display some degree of bioactivity.

II. Previous Syntheses of Centrolobine

18

Hasegawa, M.; Miura, T.; Kuzuya, K.; Inoue, A.; Ki, S. W.; Horinouchi, S.; Yoshida, T.; Kunoh, T.; Koseki, K.;
Mino, K.; Sasaki, R.; Yoshida, M.; Mizukami, T. ACS Chem. Biol. 2011, 6, 229. DOI: 10.1021/cb100248e
19
(a) I.L. De Albuquerque, C. Galeffi, C.G. Casinovi, G.B. Marini-Bettòlo Gazz. Chim. Ital. 1964 287. (b) C.
Galeffi, C.G. Casinovi, G.B. Marini-Bettòlo Gazz. Chim. Ital. 1965, 95. (c) Aragao Craveiro, A.; da Costa Prado,
A.; Gottlieb, O. R.; Welerson de Albuquerque, P. C. Phytochemistry 1970, 9, 1869. (d) Alcantara, A. F. de C.;
Souza, M. R.; Pilo´-Veloso, D. Fitoterapia 2000, 71, 613.
20
Brewster, J. H. J. Am. Chem. Soc. 1959, 81, 5483.
21
Nagarjuna, B.; Thirupathi, B.; Rao, C. V.; Mohapatra, D. K. Tetrahedron Lett. 2015, 56, 4916. DOI:
10.1016/j.tetlet.2015.06.084
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The interesting biological activity of centrolobine 7 has stimulated much interest in the
synthesis of this compound. 22, 23 As noted above, the tetrahydropyran structure is common
throughout natural products, and the successful synthesis of centrolobine 7 may be extended to
other compounds. Lastly, the simplicity of centrolobine 7 makes it a useful target to demonstrate
new methods for tetrahydropyran synthesis.

a) First Enantioselective Synthesis of Centrolobine
The first enantioselective total synthesis of (-)-centrolobine 7, reported by Colobert in
2002, resulted in the determination of its absolute configuration. 24 The key steps in the synthesis
are the intramolecular cyclization of an enantiopure β-hydroxysulfoxide 9 and the
stereoeselective reduction of β-ketosulfoxide 10. Colobert’s retrosynthetic analysis of
centrolobine 7 is shown below in Scheme 1.

22

(a) Vyvyan, J.; Longworth, H.; Nguyen, S. Synlett 2016, 27, 2221; (b) Hyoungsu, K.; Lee, D. Synlett 2015, 26,
2583; (c) Latif, M.; Yun, J. I.; Seshadri, K.; Kim, H. R.; Park, C. H.; Park, H.; Kim, H.; Lee, J. J. Org. Chem. 2015,
80, 3315; (d) Yang, Z.; Kim, H.-D. Tetrahedron: Asymmetry 2014, 25, 305; (e) Zeng, J.; Tan, Y. J.; Ma, J. Chem.
Eur. J. 2014, 20, 405; (f) Sudarshanand, K.; Aidhen, I. S. Eur. J. Org. Chem. 2013, 2298; (g) Kumaraswamy, G.;
Rambabu, D. Tetrahedron: Asymmetry 2013, 24, 196; (h) Xie, J.-H.; Guo, L.-C.; Yang, X.-H.; Wang, L.-X.; Zhou,
Q.-L. Org. Lett. 2012, 14, 4758; (i) Ahmed, N.; Konduru, N. K. Beilstein J. Org. Chem. 2012, 8, 177; (j) Fujioka,
H.; Yahata, K.; Kubo, O.; Sawama, Y.; Hamada, T.; Maegawa, T. Angew. Chem., Int. Ed. 2011, 50, 12232; (k)
Schmidt, B.; Hölter, F.; Kelling, A. J. Org. Chem. 2011, 76, 3357; (l) Clarke, P. A.; Sellars, P. B.; Mistry, N.
Tetrahedron Lett. 2011, 52, 3654; (m) Iqbal, M.; Mistry, N.; Clarke, P. A. Tetrahedron 2011, 67, 4960; (n) Jeong,
Y.; Kim, D.-Y.; Choi, Y.; Ryu, J.-S. Org. Biomol. Chem. 2011, 9, 374; (o) Reddy, C. R.; Madhavi, P. P.;
Chandrasekhar, S. Synthesis 2011, 1, 123; (p) Schmidt, B.; Berger, R.; Hölter, F. Org. Biomol. Chem. 2010, 8, 1406;
(q) Reddy, C. R.; Madhavi, P. P.; Chandrasekhar, S. Tetrahedron: Asymmetry 2010, 21, 103; (r) Chazadaj, W.;
Kowalczyk, R.; Jurczak, J. J. Org. Chem. 2010, 75, 1740; (s) Haruhiko, F.; Kenkichi, N.; Makoto, S. Heterocycles
2010, 82, 641; (t) Mohapatra, D. K.; Pal, R.; Rahaman, H.; Gurjar, M. K. Heterocycles 2010, 1, 219; (u) Schmidt,
B.; Hölter, F. Chem. Eur. J. 2009, 15, 11948; (v) Takeuchi, T.; Matsuhashi, M.; Nakata, T. Tetrahedron Lett. 2008,
49, 6462; (w) Dziedzic, M.; Furman, B. Tetrahedron Lett. 2008, 49, 678; (x) Prasad, K. Tetrahedron 2007, 63,
1089; (y) Böhrsch, V.; Blechert, S. Chem. Commun. 2006, 1968; (z) Lee, A. C.-H. Tetrahedron Lett. 2006, 47,
1641.
23
(a) Clarke, P. A.; Santos, S. Tetrahedron Lett. 2005, 46, 6651. (b) Jennings, M. P.; Clemens, R. T. Tetrahedron
Lett. 2005, 46, 2021; (c) Clarke, P. A.; Martin, W. H. C. Tetrahedron 2005, 61, 5433; (d) Lee, E.; Kim, H. J.; Jang,
W. S. Bull. Korean Chem. Soc. 2004, 25, 1609; (e) Evans, P. A.; Cui, J.; Gharpure, S. J. Org. Lett. 2003, 5, 3883; (f)
Colobert, F.; Carreño, M. C.; Mazery, R. D.; Urbano, A.; Colobert, F.; Solladie, G. J. Org. Chem. 2003, 68, 7779;
(g) Mazery, R. D.; Solladie, G.; Carreño, M. C. Org. Lett. 2002, 4, 1723; (h) Marumoto, S. Org. Lett. 2002, 4, 3919.
24
Colobert, F. C. A.; Mazery, R. D.; Solladié, G.; Carreño, M. C.. Org. Lett. 2002, 4, 172. DOI: 10.1021/ol025778z
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Preparation of (-)-centrolobine was anticipated from the aldehyde 8 with introduction of
the final side chain by Wittig reaction and reduction. In turn, preparation of aldehyde 8 could be
achieved by cyclization of the β-hydroxysulfoxide 9 prepared by stereoselective reduction of the
chiral β-ketosulfoxide 10. This step introduced the absolute chirality to the scheme. βKetosulfoxide 10 was expected from the condensation reaction between glutaric anhydride 11
and sulfoxide 12.
Scheme 1:

The first step in Colobert’s synthesis is formation of carboxylic acid 13 by the
condensation of glutaric anhydride 11 and the carbanion of (+)-(R)-methyl-p-tolyl sulfoxide 12
(Scheme 2). Esterification of carboxylic 13 to form β-ketosulfoxide 10 was completed by
deprotonation and treatment with dimethylsulfate to give β-ketosulfoxide 10 in 82% yield from
glutaric anhydride 11. The yield of this literature sequence was improved by running the
condensation reaction at -78°C. β-Ketosulfoxide 10 was reduced stereoselectively to give the βhydroxysulfoxide 9 in 80% yield and 98% diasteriomeric excess (de) using diisobutylaluminum
hydride (DIBAL) and zinc bromide. The stereochemistry of compound 9 was confirmed by

8
comparison of the 1H NMR spectrum to an authentic sample. The β-hydroxysulfoxide 9 was
transformed into hydroxyketone 15 by treatment of the intermediate Weinreb amide 14 with a
Grignard reagent, affording ketone 15 in 66% yield over two steps.

Scheme 2:

Formation of the tetrahydropyran 16 was investigated next. The inital approach to
tetrahydropyran 16 involved cyclization of hydroxyketone 15 under acidic conditions in an effort
to isolate a hemiketal 17 that could subsequently be reduced to give the desired compound 16
(Scheme 3). Under these conditions, a mixture of dihydropyran 18 and starting sulfoxide 15 was
recovered. None of the anticipated hemiketal 17 was observed under these acidic conditions.
Scheme 3:

9

In an alternate approach, Colobert attempted to prepare the tetrahydropyran 16 using a
reductive condensation reaction inspired by the work of Olah and Nicolaou. 25,26 Using an excess
of triethylsilane and trimethylsilyl trifluoromethanesulfonate (TMSOTf) the desired sulfoxide
derivative 16 was obtained from hydroxyketone 15 in 81% yield and with complete syn
stereoselectivity at the C2 and C6 positions (Scheme 4). The stereochemistry was confirmed by
NOESY experiments.
Scheme 4:

With conditions for the preparation of sulfoxide 16 were optimized, the synthesis of (-)centrolobine was completed by the conversion of sulfoxide 16 aldehyde 8 in 82% yield using
Pummerer conditions (Scheme 5). Subsequent formation of the olefin 18 was achieved by Wittig
reaction of aldehyde 8 with benzyltriphenylphosphonium salt 17 (95%). Finally, catalytic

25

Sassaman, M. B.; Kotian, K. D.; Prakash, G. K. S.; Olah, G. A. J. Org. Chem. 1987, 52, 4314. DOI:
10.1021/jo00228a031
26
Nicolaou, K. C.; Hwang, C.-K.; Nugiel, D. A. J. Am. Chem. Soc, 1989, 111, 4136. DOI: 10.1021/ja00193a076

10
hydrogenation reduced the double bond and removed the benzyl ether protecting group of olefin
18 to give (-)-centrolobine 7 in 93% yield. The enantioselective synthesis of (-)-centrolobine 7
was achieved in nine steps and 26% overall yield from glutaric anhydride 11.

Scheme 5:

1

H and 13C NMR spectra, IR spectra, melting point, and optical resolution of the

synthesized product were all identical to those of naturally occuring centrolobine 7, confirming
that the synthesized compound was the same as the target natural product. As a result of this
work, the absolute stereochemistry of (-)-centrolobine 7 was revised by Colobert from [2(R),
6(S)] to [2(S), 6(R)] based upon the configuration of β-hydroxysulfoxide 9.
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b) Hetero-Diels-Alder Reaction to Synthesize Centrolobine
In 2007, Hashimoto applied the hetero-Diels-Alder (HDA) reaction to synthesize (-)centrolobine 7 and one of its analogs. 27 The hetero-Diels-Alder reaction is a commonly strategy
for construction of tetrahydropyran targets. 28 Hashimoto was the first to synthesize
diarylheptanoid tetrahydropyran srructures employing the hetero-Diels-Alder reaction.
Hashimoto envisioned the preparation of centrolobine 7 was envisioned from chiral
ketone 19, the product of the hetero-Diels-Alder key reaction, by catalytic hydrogenation of the
triple bond and removal of the carbonyl group (Scheme 6). Hashimoto had previously reported
that dirhodium(II) tetrakis-[(R)-3-(benzene-fused-phthalimido)-2-piperidinonate], Rh2-(RBPTPI)4, is an efficient Lewis acid catalyst for enantioselective hetero-Diels-Alder reactions. 29
Using this catalyst in the cyclization, the key intermediate ketone 19 would be prepared from
protected diene 20 and phenylpropargyl aldehyde 21.
Scheme 6:

27

Washio, T.; Yamaguchi, R.; Abe, T.; Nambu, H.; Anada, M.; Hashimoto, S. Tetrahedron 2007, 63 12037. DOI:
10.1016/j.tet.2007.09.003
28
(a) Danishefsky, S. J. Aldrichimica Acta 1986, 19, 59; (b) Danishefsky, S. Chemtracts: Org. Chem. 1989, 2, 273;
(c) Boger, D. L.; Weinreb, S. M. Hetero Diels–Alder Methodology in Organic Synthesis; Academic: New York, NY,
1987; Vol. 47; (d) Weinreb, S. M. Comprehensive Organic Synthesis; Paquette, L. A., Ed.; Pergamon: Oxford,
1991; Vol. 5, p 401; (e) Boger, D. L. Comprehensive Organic Synthesis; Paquette, L. A., Ed.; Pergamon: Oxford,
1991; Vol. 5, p 451; (f) Jørgensen, K. A. Angew. Chem., Int. Ed. 2000, 39, 3558; (g) Kobayashi, S.; Jørgensen, K. A.
Cycloaddition Reactions in Organic Synthesis; Wiley-VCH: Weinheim, Germany, 2002.
29
Anada, M.; Washio, T.; Shimada, N.; Kitagaki, S.; Nakajima, M.; Shiro, M.; Hashimoto, S. Angew. Chem., Int.
Ed. 2004, 43, 2665. DOI: 10.1002/anie.200453821
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To prepare diene 20, 4-methoxybenzaldehyde 22 was treated with acetone and aqueous
sodium hydroxide to form α,β-unsaturated ketone 23 (Scheme 7) in 79% yield. 30 The ketone was
protected using Et3SiOTf and triethylamine to produce the desired diene 20.
Scheme 7:

Phenylpropargyl aldehyde 21 was prepared by protection of the hydroxyl group on
commercially available 4-iodophenol 24 with methanesulfonyl chloride 25 to form

30

Knölker, H.-J.; Ahrens, B.; Gonser, P.; Heininger, M.; Jones, P. G. Tetrahedron 2000, 56, 2259. DOI:
10.1016/s0040-4020(99)01109-6.
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methansulfonate 26. 31 Phenylpropargyl aldehyde 21 was prepared in two steps by the
Sonogashira coupling of methanesulfonate 26 with propargyl alcohol 27 and subsequent DessMartin oxidation. 32
Scheme 8:

To prepare centrolobine 7, the the Diels Alder cyclization of with diene 20 and
phenylpropargyl aldehyde 21 was carried out in the presence of Rh2-(R-BPTPI)4 28 (Figure 2).
Subsequent treatment with tetra-n-butylammonium fluoride (TBAF) removed the silyl group to
form ketone 19 in 87% yield and 93% enantiomeric excess (Scheme 9). The absolute
stereochemistry of ketone 19 was established as (2R,6S) by the transformation into (-)centrolobine 7.
Figure 2:

31

Lee, T.-S.; Kim, J.; Bae, J.-Y. Polymer 2004, 45, 5065. DOI: 10.1016/j.polymer.2004.05.051
Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 50, 4467. DOI: 10.1016/S00404039(00)91094-3
32
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Catalytic hydrogenation of ketone 19 in 95% yield to reduced the triple bond to form
ketone 29. The carbonyl group on ketone 29 was removed and formation the tosylhydrazone
with p-toluenesulfonyl hydrazine (TsNHNH2). Reduction with sodium cyanoborohydride
(NaBH3CN) in the presence of p-toluenesulfonic acid formed tetrahydropyran 30 in 75% yield.
The methanesulfonyl group of tetrahydropyran 30 was removed using potassium carbonate in
methanol to form centrolobine 7.

Scheme 9:
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Hashimoto’s synthesis provided (-)-centrolobine 7 in 41% overall yield over 7 steps
starting with methanesulfonate 26. The asymmetric hetero-Diels-Alder reaction can also be
applied to synthesize other diarylheptanoid natural products.

c) Chemoenzymatic Synthesis of the Four Stereoisomers of Centrolobine
In 2015, Mohapatra designed a chemoenzymatic approach that can be used to produce all
four stereoisomers of centrolobine 7 (Figure 3). 33 All of the stereoisomers can be synthesized
from the same starting material, 4-methoxybenzaldehyde 22. The key steps of this strategy

33

Nagarjuna, B.; Thirupathi, B.; Rao, C. V.; Mohapatra, D. K. Tetrahedron Lett. 2015, 56, 4916. DOI:
10.1016/j.tetlet.2015.06.084
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include enzymatic resolution, a cross-methasis reaction, and a tandem isomerization following a
protocol developed in the Mohapatra lab. 34.
Figure 3:

Both (-)-centrolobine 7 and (2S,6S)-epi-centrolobine 31 could be prepared by catalytic
hydrogenation of ketone 34 (Scheme 10). Ketone 34 was anticipated from tetrahydropyran 35
using Jin’s hydroxylation-oxidation protocol and a Grignard reaction. Tandem isomerization
followed by C-C and C-O bond formation would produce tetrahydropyran 35 from aldehyde 36.
A cross-metathesis reaction would yield aldehyde 36, which was expected from the enzymatic
resolution of alcohol 37. Alcohol 37 would be produced from a Grignard reaction of
commercially available methoxybenzaldehyde 22.

34

Mohapatra, D. K.; Bhimireddy, E.; Krishnarao, P. S.; Das, P. P.; Yadav, J. S. Org. Lett. 2011, 13, 744. DOI:
10.1021/ol1029854
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Scheme 10:

The remaining two stereoisomers of (-)-centrolobine 7, (+)-centrolobine 32 and (2R,6R)epi-centrolobine 33, would result from a similar synthetic plan. The diastereomers would be
formed by catalytic hydrogenation of the common intermediate ketone 38 (Scheme 11). The
ketone intermediate 38 would be formed from the tetrahydropyran 39 using Jin’s hydroxylationoxidation protocol and a Grignard reaction. Tandem isomerization followed by C-C and C-O
bond formation was expected to give tetrahydropyran 39 from aldehyde 40. A cross-metathesis
reaction would form aldehyde 40. The side product of enzymatic resolution of alcohol 37, acetate
41, was used to form aldehyde 40.
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Scheme 11:

In the forward synthesis, preparation of the racemic alcohol 37 was achieved by addition
of allylmagnesium bromide to 4-methoxybenzaldehyde 22. Treatment of the resulting racemic
alcohol 37 with the enzyme Amano lipase PS-C II in the presence of vinyl acetate resulted in
formation of homoallylic alcohol 42 (47%, ca. 99% ee) and the enantiomerically enriched acetate
41. These compounds were separated by column chromatography. Homoallylic alcohol 42 was
then subjected to a cross-methasis reaction with acrolein in the presence of the Hoveyda-Grubbs
catalyst to form the δ-hydroxy α,β-unsaturated aldehyde 36.
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Scheme 12:

The olefin cross-metathesis reaction is one of the key steps in this synthesis. While crossmetathesis reactions had the potential to be useful in organic synthesis, it was difficult to predict
the product’s stereochemistry and selectivity. Grubbs explored the cross-metathesis reaction to
make it more applicable to organic chemists 35. First, Grubbs ranked different types of olefins
basked on their ability to homodimerize into four types. Homodimerization occurs when an
olefin undergoes the cross-metathesis reaction with itself. The more likely an olefin is to
homodimerize, then the less likely it will be to undergo the cross-metathesis reaction with a
different olefin. He then explored the reaction of each catagory with itself or with another
cataogry with all the different catalysts available. Through his work, Grubbs successfully showed
how one could predict the product of a cross-metathesis reaction based on the types of olefins
used in the reaction and the catalyst. Mohapatra’s choice of catalyst for this key step is based on

35

Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc 2003, 125, 11360. DOI:
10.1021/ja0214882
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Cossey’s work on the synthesis of octalactins, in which a successful cross metathesis reaction
using Hoveyda-Grubbs catalyst 30 and acrolein 29 as one of the compounds. 36
The second key step of Mohapatra’s synthetic plan is the cyclization of δ-hydroxy α,βunsaturated aldehyde 36 to tetrahydrpyran 35. Mohapatra developed a protocol to cyclize δhydroxy α,β-unsaturated aldehydes to trans-2,6-disubstituted-3,4-dihydropyrans using molecular
iodine as a Lewis acid and allyltrimethylsilane as a nucleophile. 37 Molecular iodine reacts with
allyltrimethylsilane 45 to form allyl iodide 46 and trimethylsilyl iodide 47 (Scheme 13). Without
the presence of iodine, the reaction will not proceed.
Scheme 13:

Activation of the carbonyl in aldehyde 48 with trimethylsilyl iodide 47 provided
compound 50, which then undergoes a conformation change to compound 51 (Scheme 14). The
hydroxyl group added to the activated carbonyl to cyclize to tetrahydropyran 51. The hydroxyl
group was deprotonated from iodine anion. Protonation of the –OTMS substituent from
hydrogen iodide provided compound 54. The lone pair on the oxygen pushed down to remove
trimethylsilanol to form olefin 55. Additional of iodine anion to the trimethylsilyl group on
allyltrimethylsilane 45 allowed for the addition of the alkene to the double bond on oxonium 55
to form tetrahydropyran 56. The steric interactions from the substituent on C2 in oxonium
intermediate 55 direct the incoming allyltrimethylsilane on the opposite side of the ring, forming
the trans product. Their protocol produced the desired product in high yields and only as the

36

Dinh, M.-T.; Bouzbouz, S.; Péglion, J.-L.; Cossy, J. Tetrahedron 2008, 64, 5703. DOI: 10.1016/j.tet.2008.04.026
Mohapatra, D. E. K.; Das, P. P.; Pattanayak, M. R.; Yadav, J. S. Chem. Eur. J. 2010, 16, 2648. DOI:
10.1002/chem.201090036
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trans isomer. Their mechanism was confirmed by treatment of δ-hydroxy α,β-unsaturated
aldehyde with a catalytic amount of trimethylsilyl iodide 47, and the corresponding trans-2,6disubstituted-3,4-dihydropyran was formed in ten minutes.
Scheme 14:

Treatment of the trans-δ-hydroxy α,β-unsaturated aldehyde 36 with allyltrimethylsilane
45 and catalytic iodine gave dihydropyran 35 as a single steroisomer (Scheme 15To complete the
synthesis, dihydropyran 35 was converted to aldehyde 57 by oxidative cleavage of the terminal
alkene. Subsequent Grignard reaction produced alcohol 58 as a 1:1 mixture of diastereomers.
This mixture was oxidized with Dess-Martin periodinane to give ketone 59. Catalytic
hydrogenation then provided the tetrahydropyran 34 that can be used to prepare either trans or
cis (-)-centrolobine isomers. The trans-pyran 34 was epimerized to the cis isomer 60 with
benzoic acid, cis pyran 60 was hydrogenated again to form (-)-centrolobine 7.
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Scheme 15:

To form the trans (-)-centrolobine 31 isomer, ketone 34 was catalytically hydrogenated to
form the desired product in 71% yield (Scheme 16):
Scheme 16:
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The synthesis of the (+)-isomers of centrolobine began by treating acetate 41 with
potassium carbonate to form the homoallylic alcohol 61 (Scheme 17). The same scheme was
followed as described above to form (+)-centrolobine 32.
Scheme 17:

24

The trans isomer of (+)-centrolobine 33 was formed by catalytic hydrogenation of
tetrahydropyran 38 (Scheme 18).
Scheme 18:

Mohapatra’s scheme for the synthesis of centrolobine is very flexible, and each
stereoisomer can be prepared in 26-28% yield from 4-methoxybenzaldehyde 22. This work
highlights the scope of the tandem isomerization reaction followed by C-O and C-C bond
formations for the synthesis of pyran complexes. The sequence design is quite versatile and can
be adopted to other natural products with structures similar to centrolobine.

d) Application of Catalytic Asymmetric Halocyclization to Synthesize Centrolobine
The most recent synthesis of centrolobine 7 was reported by Zhou. 38 The key step in this
sequence catalytic asymmetric halocyclization to form the tetrahydropyran framework based on
Zhou’s previous studies of the intra- and intermolecular haloetherification of enones.
Zhou’s general method for asymmetric intramolecular bromoetherification to form sixmembered rings was based on the discovery that L-PiPr2 66 and Fe(acac)3 67 (Figure 4) form a
complex that acted as a catalyst for the cyclization. For intermolecular haloetherification, LRaPr2 68 and Sc(OTf)3 69 proved to be better suited for the cyclization.

38

Zhou, P.; Cai, Y.; Zhong, X.; Luo, W.; Kang, T.; Li, J.; Liu, X.; Lin, L.; Feng, X. ACS Catal., 2016, 6, 7778. DOI:
10.1021/acscatal.6b02048
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Figure 4:

Once finding the best catalyst, Zhou moved onto the halogen source. N-bromo-N-methylbenzenesulfonamide (BsNMeBr) was found to be the ideal bromine source. Using the optimized
conditions, the desired product for bromocyclization was produced in high yields and high
enantioselectivity (Scheme 19). Additionally, the same conditions can be applied to chloro- and
iodocyclizations where N,N-dichloro-p-nitrobenzenesulfonamide (p-NsNCl2) was the chlorine
source and N-iodosuccinimide (NIS) was the iodine source. He examined the scope of the
chlorocyclization using different enones.
Scheme 19:
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Next, Zhou attempted to use the same conditions to form seven-membered chiral
oxepanes. However, the conditions only produced 40% ee for the major isomer. The conditions
were optimized again and he discovered that changing the metal from Fe(acac)3 to Ce(OTf)3 and
adding m-chloroperbenzoic acid as a proton additive greatly improved the enantioselectivity.
Again, the scope of the seven-membered chloro- and bromocyclization was investigated.
Once the protocol for intermolecular haloetherification was developed, Zhou began to
explore intramolecular haloetherification. The haloetherification would be facilitated from the
chalcone and an external alcohol would be the nucleophile. The reaction conditions were
optimized and they found the complex L-RaPr2 68/Sc(OTf)3 69 for the catalyst, methanol for the
nucleophile, and running the reaction in toluene at 35°C produced the best results. Zhou reported
the first asymmetric haloetherification of chalcones using his protocol.
Zhou applied his methodology to the synthesis of (-)-centrolobine 7. Following his
protocol, centrolobine 7 was projected from the tetrahydropyran 73. Tetrahydropyran 73 would
be formed by bromocyclization of the corresponding enone 74 (Scheme 20). The enone 74 was
produced by the cross-metathesis reaction of α,β-unsaturated ketone 75 and alcohol 76.
Scheme 20:
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Formation of α,β-unsaturated ketone 75 could proceed by treatment of p-hydroquinone
78 with acryloyl chloride 77 to form phenyl acrylate 79 based on literature procedures. 39
Reacting phenyl acrylate 79 with aluminum chloride at reflux formed alcohol 80, which also
could be completed by literature procedures. 40 Subsequent protection of the hydroxyl on alcohol
80 would produce the desired α,β-unsaturated ketone 75.
Scheme 21:

Formation of alcohol 76 could proceed by reduction of acetate 81 with lithium aluminum
hydride (Scheme 22) to form alcohol 82 following literature procedures. 41 Oxidation of alcohol
82 with 2-iodoxybenzoic acid 83 would produce aldehyde 84, also based on literature
procedures. 42 Subsequent Grignard reaction of aldehyde 84 formed the desired alcohol 76
following literature procedures. 43

39

Kim, J. H.; Park, E.-S.; Shim, J. H.; Kim, M.-N.; Moon, W.-S.; Chung, K.-H.; Yoon, J.-S. J. Agric. Food Chem.
2004, 52, 7480. DOI: 10.1021/jf0499018
40
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Silvestri, R. J. Med. Chem. 2012, 55, 5627. DOI: 10.1021/jm201485c
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Scheme 22:

Cross-metathesis reaction of α,β-unsaturated ketone 75 and alcohol 76 (Scheme 23)
formed enone 74. 44 Enone 74 was treated with 10% Fe(acac)3/L-PiPr2 in the presence of the
brominating reagent BsNMeBr to form ketone 73 and (+)-alcohol 86 in >93% and 99% ee,
respectively. Ketone 73 was debrominated to form tetrahydropyran 87 in 99% enantiomeric
excess after purification. Tetrahydropyran 87 was deoxygenated using LiBH4 to give compound
88. An Ullman cross coupling of compound 88 yielded compound 89; deprotection of the benzyl
ether provided (-)-centrolobine 7.

44

Lu, Y.; Zou, G.; Zhao, G. ACS Catal. 2013, 3, 1356. DOI: 10.1021/cs4002332
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Scheme 23:

Zhou’s inter- and intramolecular asymmetric haloetherification provides a useful method
to form chiral tetrahydropyrans and oxepanes. The mild reaction conditions and broad substrate

30
scope make the haloetherification applicable to produce unique tetrahydropyran systems.
Additionally, the high yields and good to excellent enantiomeric excess also make the
haloetherification reaction even more useful to produce compounds stereoselectively. The
application of his reaction towards the synthesis of centrolobine 7 can also be applied to the
synthesis of other natural products with a similar tetrahydropyran framework.
The examples included are only a few of the many syntheses of centrolobine 7. The
synthesis of centrolobine 7 can highlight the new and different methods of tetrahydropyran
preparation.

III. Carbonyl Ene Reaction of Exocyclic Enol Ethers
The Totah group has demonstrated the use of 2-methylenetetrahydropyrans in the
carbonyl ene reaction with aldehydes and electron deficient ketones (Scheme 24). 45
Scheme 24:

The benefits of the carbonyl ene reaction of exocyclic enol ethers include the mild
reaction conditions, the use of catalytic Lewis acid, and high yields ranging from 69-99%.
Additionally, broad substrate scope (Table 1) allows for the formation of a wide range of
tetrahydropyran systems. The reaction works well with both electron rich, as shown by the 95%

45

(a) Liang, G.; Bateman, L. J.; Totah, N. I. Chem. Commun. 2009, 6457. DOI: 10.1039/b916190b (b) Liang, G.;
Sharum, D. T.; Lam, T.; Totah, N. I. Org. Lett. 2013, 15, 5974. DOI: 10.1021/ol402843s
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yield of the reaction with 4-methoxybenzaldehyde 22 and electron deficient aldehydes, as shown
by the 90% yield of the reaction with p-nitrobenzaldehyde 95.

Table 1:

32
This methodology provides a direct route for the preparation of substituted
tetrahydropyrans, and the results discussed above suggest that this method will be useful for the
preparation of tetrahydropyran natural products. Application of this method toward the synthesis
of centrolobine is discussed in the following chapter.
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Chapter 2

Results and Discussion

I. Synthetic Plan
Previous work in the Totah lab has demonstrated the utility of the carbonyl ene reaction of
exocyclic enol ethers for the formation of functionalized pyran deriviatives.45 Application of this
chemistry to the synthesis of centrolobine 7 is outlined below (Scheme 25). Formation of the
natural product is expected in two steps from alcohol 109: simultaneous reduction of both
hydroxy and alkene groups in alcohol 109 then cleavage of the protecting group on the phenol.
In turn, alcohol 109 can be prepared using the carbonyl ene reaction of an exocyclic enol ether.
In the key step, the centrolobine framework is derived from two components – an exocyclic enol
ether 110 and a suitably protected aldehyde 11. The exocyclic enol ether can be synthesized from
the corresponding lactone 112 via the Petasis reaction. 46 Lactone 112 can be prepared in three
steps from commercially available anisole 114 and glutaric anhydride 22. In this sequence, the
desired syn stereochemistry at the C2 and C6 carbons of centrolobine 7 is expected upon
reduction of the double bond in alcohol 109. Attack of the hydride opposite the C6 aromatic side
chain will control the sterochemistry at C2.

46
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Scheme 25:

II. Lactone Synthesis
To begin the synthesis of centrolobine 7, the components for the ene were prepared. First
was the synthesis of lactone 112, prepared in three steps from commercially available glutaric
anhydride 22 and anisole 114.

a. Preparation of the Ketoacid
The first step in the synthesis of lactone 112 was the Friedel-Crafts acylation of glutaric
anhydride 22 with anisole 114 to form the carboxylic acid 113. Following a procedure reported
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by Dillard, these reactants were combined in the presence of aluminum chloride and stirred at
0°C. 47 The effect of stoichiometry and reaction time are shown in Table 2.

Table 2:

Entry

Scale

Reaction Time
3.5 h

Acidification
Time
20 mins

1

5g

2

Yield
104%

5g

3h

12 h

79%

3

10 g

17 h

10 min

N/A

4

5g

18 h

30 min

68%

For entry 1, the reaction was completed successfully and after acidification the crude
product was isolated. Recrystallization with ethyl acetate was attempted in an effort to purify the
compound. However, because the yield of the purified compound was higher than 100% and the
melting point, 163-169°C, was higher than the literature reported values of ketoacid 113, 140141°C, the desired product was not obtained. 48 Subsequent purifications were completed using
ethanol which was the solvent used to recrystallize ketoacid 113 in the procedure.

47

Dillard, R. D.; Hahn, R. A.; Mccullough, D.; Carr, F. P.; Rinkema, L. E.; Roman, C. R.; Fleisch, J. H. J. Med.
Chem. 1991, 34, 2768. DOI: 10.1021/jm00113a014
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In order to obtain larger quantities of starting material, the reaction was run on a larger
scale. In one case (entry 3), 10 g of glutaric anhydride was utilized and the reaction stirred for 17
hours, much longer than the previous attempts. After three hours, TLC of the reaction mixture
indicated the presence of glutaric anhydride 22, so the reaction was allowed to continue
overnight. Unfortunately, repeated attempts to recrystallize the crude material were not
successful; no crystals formed even when the ethanol solution was concentrated or when seed
crystals of the pure carboxylic acid 113 were added to in an attempt to induce recrystallization,
At this point a small sample of the solution was concentrated via rotary evaporator and a
evaluated by 1H NMR. This spectrum showed significant impurities, and carboxylic acid 40 was
present only as minor product. This factor prevented it from recrystallizing.
Examination of the original 1H NMR revealed that the crude reaction mixture contained
the diethyl ester of glutaric acid 115. It was suspected that the crude crystals of the carboxylic
acid 113 were not rinsed sufficiently during the filtration and still contained both HCl and
glutaric anhydride 22. When hot ethanol was added to recrystallize the product, the residual HCl
catalyzed the reaction of ethanol with glutaric anhydride 22 to form the diethyl ester of glutaric
anhydride 115 as shown (Scheme 26). Attempts to separate the desired carboxylic acid 113 by
extraction of this mixture with 5% NaOH were not successful. Efforts to isolate carboxylic acid
113 were ceased.
Scheme 26:

Due to the difficulties encountered in scale-up attempt, the scale of the reaction was
reduced to 5 g, and the synthesis attempted for a fourth time (entry 4). The mixture was allowed
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to stir in acid for 30 minutes to ensure complete protonation, and the crude crystals were filtered.
Drying was continued overnight using the vacuum filtration apparatus. A crude 1H NMR of the
resulting product showed no sign of impurities. No recrystallization was necessary, and a 68%
yield of pure carboxylic acid 113 was obtained.
To ensure success of the Friedel-Crafts acylation of glutaric anhydride 22 and anisole
114, all product must be protonated during the acidic workup. If the reaction is run on a larger
scale then the crude product must be washed thoroughly to prevent the formation of by-products
during recrystallization. Cold ethanol is crucial during this process to ensure the crude material
does not dissolve. Lastly, recrystallization may not be necessary as shown by excellent results in
the last experiment (entry 4). Others have reported the preparation and use of carboxylic acid 113
without purification. 49

b. Ketone Reduction
With preparation of the carboxylic acid 113, the next step was reduction of the ketone
functional group to the alcohol 116 (Table 3). This reaction was based on a procedure reported
by Chiappe for the synthesis of 6-phenylvalerolactone. 50

49
50

McCalmot, W.F. Bioorg. Med. Chem. 2005, 13, 3821. DOI: 10.1016/j.bmc.2005.03.004
Boschi, A.; Chiappe, C.; De Rubertis, A.; Ruasse, M.F. J Org. Chem. 2000, 65, 8470. DOI: 10.1021/jo000799x
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Table 3:

Entry

Scale

NaBH4

Reaction
Time

% Yield
Alcohol

% Yield
Lactone

1

0.5 g

1.8 eq

48 h

17%

1%

2

2g

1 eq

24 h

21%

1%

3

1g

4 eq

45 h

36%

4%

4

0.5 g

3 eq

48 h

92%

5%

5

2g

3 eq

48 h

83%

8%

6

1.4 g

2 eq

40 h

62%

32%

7

5g

2 eq

48 h

81%

12%

Following the procedure, the ketoacid 113 was dissolved in 5% NaOH then 1.2
equivalents of NaBH4 was added (entry 1). Normally, sodium borohydride reductions are
conducted in ethanol. However, the carboxylic acid 42 is not very soluble in this solvent. In
order to adjust, the reaction is run in 5% NaOH in water. The sodium hydroxide deprotonates
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carboxylic acid 113, and the resulting sodium salt dissolves in the aqueous solution. The reaction
stirred at room temperature for 24 hours and after checking the reaction by TLC, there was still a
large amount of starting material present. An additional 0.6 equivalents of NaBH4 was added and
stirred at room temperature for an additional 24 hours. The mixture was acidified and extracted
immediately after using CH2Cl2. The crude 1H NMR showed the presence of both alcohol 116
and lactone 112. These compounds could be separated by column chromatography, and
recovered alcohol 116 in 17% yield and lactone 112 in 1% yield.
Initially, the reduction of carboxylic acid 113 was quite troubling; the yields reported
were at best 22% and a large amount of starting material was present even after 48 hours of
reaction time (entries 1,2). One contributor to the poor yields could be the hydrolysis of NaBH4.
Since the reaction must be run in 5% NaOH, some NaBH4 hydrolyzes to form hydrogen gas and
oxido(oxo) borane as shown in Scheme 27. 51
Scheme 27:

To accommodate for the possible hydrolysis of sodium borohydride, the amount of
reagent used was increased. In entry 1, additional NaBH4 was added after 24 hours because TLC
did not show completion. In entry 2, after 24 hours the reaction showed completion by TLC so
additional NaBH4 was not added. In entry 3, excess NaBH4 was used at the start of the reaction
and was added after 24 hours because TLC did not show completion.

51
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Another step to ensure the reduction of all of carboxylic acid 40 was to use vigorous
stirring. Even though carboxylic acid 113 will dissolve in 5% NaOH, it does so slowly. With
gentle stirring, some of carboxylic acid 113 remained stuck on the side of the flask where it
cannot be reduced. By using a larger flask for the reaction, more vigorous stirring can be
accomplished so that all of the starting material can be dissolved.
When sodium borohydride was added to the aqueous reaction mixture, the hydrogen gas
that formed caused the mixture to bubble slowly. Over time, these bubbles formed a foam above
the reaction solvent that contained some carboxylic acid 113. When trapped in this foam, the
carboxylic acid could not be reduced, as it was not in solution.
This problem was addressed in two ways in the next reaction (entry 3). First, the use of a
larger flask with more vigorous stirring helped to break up the foam and re-dissolve the
carboxylic acid. Second, adding sodium borohydride to the reaction mixture in portions
minimized the rate of hydrogen gas formation, and in turn reduced the amount of foam that was
formed.
As noted above, incomplete protonation of the carboxylic acid salt during the reaction
workup can also lead to poor yields. In the next reaction (entry 3), the following steps were taken
to ensure that protonate the carboxylic acid salt 116 was complete. First, the pH of the reaction
mixture was checked during workup to be sure enough aqueous Hall was added to acidify the
solution. The mixture was then stirred for 30 minutes and the pH checked again. If needed, more
acid was added with stirring to be sure that all of alcohol 116 could be recovered from the
aqueous layer.
In addition, it was determined that alcohol 116 does not dissolve well in
dichloromethane, and that when this solvent was used for extraction, the majority of the product
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remained in the aqueous layer. Again in the next reaction (entry 3), the aqueous layer was
saturated with sodium chloride to prior to extraction in an attempt to move more of the product
into the organic layer. Even with all the measures taken as described above for entry 3, the yields
still remained low at 40%.
In a final effort to improve the yield of this reaction the choice of extraction solvent was
investigated (entry 4). The reduction was set up as described above, but during work up the
solvent used in the extraction was changed from dichloromethane to ethyl acetate. Since ethyl
acetate is more polar than dichloromethane, it was anticipated that alcohol 116 would dissolve
more readily in this solvent. This expectation was confirmed by TLC. After extracting the
aqueous layer three times with ethyl acetate, TLC of a small fourth extract confirmed that all of
the product 116 had been recovered and the yield improved to 97% yield. Following these
adjustments, yields remained high for subsequent reactions (entries 5-7).
Overall, efforts to improve the yield of the reduction of ketoacid 113 were extremely
successful. Adding an excess of NaBH4 at the beginning of the reaction and additional after 24
hours if needed ensured that all of the starting material can be reduced. Vigorous stirring
dissolved all of ketoacid 113 into the reaction mixture and helped break up the foam containing
ketoacid 113 that formed upon addition of NaBH4. Changing the extraction solvent from
dichloromethane to ethyl actetate extracted all of alcohol 116 from the aqueous reaction mixture,
which greatly contributed to the improved yields.

c. Cyclization of the Ketoalcohol
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The cyclization of alcohol 116 to lactone 112 (Scheme 28) was conducted based on a
procedure published in a patent by Sato in 1998. 52 In that report, 4-(4-methoxyphenyl)butyric
acid was cyclized to γ-(4-methoxyphenyl)-γ-butyrolactone. The same reaction conditions were
used to cyclize alcohol 116 to lactone 112.
Scheme 27:

The reaction of alcohol 116 with isobutyl chloroformate 117 proceeded smoothly to form
the desired lactone 112. There were not any issues during this reaction and the conditions were
followed exactly as written in the literature every time. Over time, yields for the reaction
decreased from 98% to 64%. One possibility for the decreased yields could be the age of the
reagent isobutyl chloroformate 117. The use of new reagent would presumably bring yields back
to the initial level. Because the lower yields were identified towards the end of the research, this
option was not pursued. The reduction ketoacid 113 and the cyclization reaction were able to
generate substantial quantities of lactone 112 for use in subsequent experiments.

II. Preparation of Carbonyl Ene Components
The next stage in the synthesis of centrolobine 7 was preparation of the components for
the ene reaction. The exocyclic enol ether 110 was prepared from lactone 112 via the Petasis
reaction. Several types of aldehydes were expected to be used; some were commercially
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available and others were not. The aldehyde needed for centrolobine 7 synthesis was not
commercially available and was prepared from 4-hydroxybenzaldehyde 124. Successful
preparation of these components sets the stage for the key step of this synthesis.

a. Synthesis of the Exocyclic Enol Ether
Preparation of the exocyclic enol ether 110 could be achieved by treatment of lactone 112
with dimethyltitanocene 119, the Petasis reagent.45 This reagent was named after its founder
Nicos Petasis in 1990 and can be used for the methylenation of aldehydes, ketones, α,β
unsaturated ketones, esters and lactones. For this sequence the Petasis reagent was prepared
according to the method of Clauss and did not pose any difficulties. 53 The preparation of this
reagent is shown below in Scheme 28.
Scheme 28:

Lactone 112 was then treated with 2 equivalents of Petasis reagent 119 and the resulting
mixture warmed to reflux overnight (Table 4, entry 1). Upon cooling, the reaction mixture was
diluted with hexanes, then the mixture filtered and concentrated again to give the crude exocylic
enol ether 110. This process was used to remove some of the titanium by-products from the
reaction mixture. Exocyclic enol ether 37 is very soluble in hexanes but by-products from the
Petasis reagent are not.
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Table 4:

Entry

Scale

Reaction Time

Exo:Endo

% Yield

1

0.1 g

25 h

1:1

45%

2

0.1 g

25 h

13:8

21%

3

0.2 g

25 h

11:10

39%

4

0.2 g

25 h

5:2

31%

5

0.5 g

22 h

9:5

28%

6

0.1 g

25 h

9:2

24%

7

0.2 g

24 h

1:1

36%

In the presence of acid, exocyclic enol ethers 120 are prone to isomerization to give the
more stable endocylic enol ether 121. In the presence of water, hydrolysis may also occur
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(Scheme 29). For these reasons, some precautions were taken during workup, purification, and
characterization of the lactone product 110.
Scheme 29:

Use of the workup procedure described above minimized the chance of hydrolysis since
no water was used in the process. Additional steps were taken in an effort to prevent
isomerization from occurring. First, because the silica gel used in column chromatography is
slightly acidic, solvents used to pack and elute the product during column chromatography all
contained 5% triethylamine. This process deactivates the silica and makes it more basic. Second,
the CDCl3 solvent in which the product was dissolved in order to take 1H NMR spectra was
filtered through a plug of basic alumina immediately before use. As a further precaution, the
CDCl3 was also removed from the sample in vacuo immediately after taking the 1H NMR.
Unfortunately, the first time the reaction was conducted (entry 1) no triethylamine was
included in the solvent used to pack the silica nor to elute the product during purification. As a
result most of the product isolated was the endocyclic enol ether 123 (Figure 5). A 1:1 ratio of
exo to endocyclic enol ethers were isolated in 45% yield. These compounds could not be
separated. In addition, both the crude and the pure 1H NMR spectra showed that a large amount
of the reagent by-products remained in the mixture.
Figure 5:
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In the second attempt to make exocyclic enol ether 110 (entry 2), the basic experiment
remained the same, but several modifications were made to the workup procedure. Upon cooling,
the reaction mixture was concentrated in vacuo to remove THF before the hexanes were added.
The crude mixture was then stirred in hexanes for 20 minutes at room temperature, then filtered
through a celite pad and concentrated again. This process greatly diminished the amount of
titanocene material remaining in the crude product based on the 1H NMR. Upon purification by
column chromatography, which included the use of triethylamine, exocyclic enol ether 110 and
endocyclic enol ether 123 were isolated in a 13:8 ratio and 21% yield.
The third attempt at the reaction (entry 3) was completed on a larger scale to prepare
sufficient material for the ene reaction. The reaction set up was followed as described above and
the crude 1H NMR showed no indication of isomerization. However due to the length of time the
compound spent in the column during the purification process, the pure 1H NMR revealed a
11:10 ratio of exocyclic enol ether to end cyclic enol ether. In subsequent reactions (entries 4-5)
a faster airflow was used during purification, which increased the ratio of exocyclic enol ether to
endocyclic enol ether.
At the fourth attempt in the reaction (entry 4), rather than letting the crude mixture stir in
hexanes for 20 minutes at room temperature, after dilution with hexanes the mixture was allowed
to sit in hexanes overnight. This process also diminished the amount of titanocene material and
improved the ratio of exocyclic enol ether to endocyclic enol ether, shown by a 5:2 ratio after
purification. This process was not completed in the following reaction (entry 5) and the ratio of
exocyclic enol ether to endocyclic enol ether decreased to 9:5.
In order to make material suitable for the ene reaction, the column chromatography step
was omitted in an effort to reduce isomerization. Removal of the titanocene impurities was
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crucial in order for the ene reaction to proceed. The process of diluting with hexanes, sitting in
the freezer overnight, and filtering through celite was completed three times. At each step, the
amount of hexanes was reduced from 30 mL in the initial dilution to 5 mL in the second and 0.5
mL in the third. Each times hexanes was added to the crude residue, more of the titanocene
byproducts precipitated out of the mixture. Using less hexanes for each dilution helped prevent
the reagent from re-dissolving into solution. The crude 1H NMR showed very little presence of
the titanocene byproducts, though some of the endocyclic enol ether was observed. Nonetheless,
enough of the desired product was present that the material could be used in the ene reaction.

b. Protection of the Aldehyde
The second component needed for the ene reaction is a protected p-hydroxyl aldehyde
derivative. The hydroxyl group needed to be protected to prevent side reactions during the ene
reaction. The acetate group was chosen because it would be stable to the conditions of the ene
reaction. The desired aldehyde was synthesized from 4-hydroxybenzaldehyde (Scheme 30)
following a literature procedure by Schmidt. 54
Scheme 30:
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4-hydroxybenzaldehyde 124 was reacted with acyl chloride and triethylamine at 0°C for
40 minutes to produce the desired protected aldehyde 111. The crude mixture was purified
through a silica plug to isolate aldehyde 111 in a 98% yield.
Once p-acetoxybenzaldehyde 111 was prepared, all the components for the key step in
the synthesis of centrolobine 7 were ready.

III. Attempted Ene Reactions
With the preparation of both the exocyclic enol ether 110 and a suitably protected
aldehyde 111, the next step was the carbonyl ene; the key step in this synthesis. Successful
execution of this step would provide the final carbon framework of centrolobine from exocyclic
enol ether 110. Both commercially available p-nitrobenzaldehyde 125 and pacetoxybenzaldehyde 111, prepared as described above were evaluated in this reaction. While
the product of the first reaction could not readily be converted to centrolobine 7, it was of interest
for the preparation of centrolobine analogs. Both reactions were conducted according to the
procedure published by Totah.45

a. Ene Reaction with p-Nitrobenzaldehyde
The reaction of exocyclic enol ether 110 with p-nitrobenzaldehyde 125 was first explored
(Scheme 31). Exocyclic enol ether 110 that had been purified by column chromatography was
used. The reactants were combined in THF, followed by addition of catalytic ZnCl2. During the
workup, the reaction mixture was concentrated directly without aqueous workup. Though pnitrobenzaldehyde 125 had previously been used successfully in ene reactions of this type, the
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crude 1H NMR showed no indication that the desired product had formed; only peaks
corresponding to p-nitrobenzaldehyde 125 were observed.
Scheme 31:

Several factors may have contributed to the failure of this reaction. First, since the
exocyclic enol ether 110 was purified by chromatography, it was possible that the compound had
isomerized to endocyclic enol ether 123 prior to the attempted ene reaction. Previous work in the
Totah lab has shown that endocyclic enol ethers do not participate in this reaction. In addition,
the reaction was carried out on a very small scale. In this situation the presence of even trace
amounts of water could result in the formation of some HCl and facilitate isomerization or even
hydrolysis of the exocyclic enol ether 110.

b. Ene Reaction with p-Acetoxybenzaldehyde
In a second attempt the ene reaction was conducted using crude exocyclic enol ether 110
and p-acetoxybenzaldehyde 111 (Scheme 32). As before, these reactants were combined, treated
with catalytic ZnCl2 and allowed to stir at rom temperature overnight. Unlike in the previous
reaction, one drop of triethylamine was added to the reaction mixture prior to concentration in
order to neutralize any HCl that might form.
Scheme 32:
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Though only a small quantity of material was isolated after column chromatography, the
1

H NMR was promising, showing peaks that could correspond to the hydrogens at C2 and C5 of

alcohol 109. Though at the point synthesis of this advanced intermediate cannot be confirmed
unequivocally, the reaction looks promising and provides a basis for further optimization. Key to
the success of this process will be the ability to generate quantities of the exocyclic enol ether
110 without isomerization.

VI. Conclusion and Future Work
Overall, significant steps were taken towards the complete synthesis of centrolobine 7 via
the ene reaction. The Freidel-Crafts acylation of glutaric anhydride 11 and anisole 114 showed to
be an effective method to produce carboxylic acid 113. The reaction conditions of the sodium
borohydride reduction to form alcohol 116 were optimized to improve the overall yield from
18% to 97%. A good method was discovered to prepare lactone 112 with few complications.
Though the results of the formation of exocyclic enol ether 110 obtained improved significantly
over the course of these studies, more work is needed to fully optimize the reaction conditions
and to prevent isomerization. Lastly, the ene reaction of exocyclic enol ether 110 with aldehyde
111 showed some promise, and paves the way for additional work.
Once the ene reaction is optimized, reduction of both the double bond and hydroxyl
group in alcohol 109 is expected to give tetrahydropyran 127 (Scheme 33). The syn
stereochemistry is expected because of the steric hinderence from substituent pointing back at
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the C2 position, so reduction will proceed from the front of the molecule. Finally, removal of the
acetate in under basic conditions will give centrolobine 7.
Scheme 33:

This route is readily modified for the preparation of centrolobine analogs. Use of
different aromatic compounds during the Friedel-Crafts acylation or different aldehydes in the
ene reaction would lead to side chain analogs of centrolobine 7. Because the 2,6 disubstituted
tetrahydropyran framework appears in a number of molecular frameworks, this synthetic plan
could potentially be applied to the synthesis of other natural products. Though more time is
needed to complete the synthesis of centrolobine 7 by this route, the ene reaction of exocyclic
enol ethers remain a viable key step for the synthesis of this and related compounds.
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Chapter 3

Experimental

General Methods:
All air sensitive reactions were performed in oven dried glassware under an argon
atmosphere. Reaction solvents were dried over CaH2 (dichloromethane) or
sodium/benzophenone ketyl (tetrahydrofuran, diethyl ether) and were distilled just prior to use.
Zinc (II) chloride was fused under vacuum immediately prior to use, then dissolved in anhydrous
THF to prepare a solution of known concentration. All other reagents were reagent grade and
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purified as necessary. Analytical thin layer chromatography was performed on EM silica gel F254
glass plates (0.25 mm). Melting points were recorded using an Electrothermal melting point
apparatus and are uncorrected. Flash chromatography was performed using SiliaFlash P60 silica
gel (40-63 μm) from SiliCycle, Inc. 1H NMR spectra were recorded on a Bruker Advance DPX300 or ASCEND-400 spectrometers. Chemical shifts are reported in ppm, downfield from
tetramethylsilane using residual CDCl3 (δ

13

7.27
C NMR
ppm)
spectra
as the internal standa

were recorded on a Bruker Avance DPX-300 (75 MHz) or ASCEND-400 (100 MHz)
spectrometers with complete proton decoupling. Chemical shifts are reported in ppm, downfield
from tetramethylsilane using residual CDCl3 as the internal standard (δ 77.0 ppm). IR spectra
were obtained with a Thermo Nicolet IR-100 spectrometer on NaCl plates. Elemental analyses
were performed on a Costech ECS 4010 elemental analyzer with a thermal conductivity detector
and 2 meter GC column maintained at 50°C. High resolution mass spectra were obtained using
the positive ion electrospray mode on a Bruker 12 Tesla APEX-Qe FTICR-MS with an Apollo II
ion source at Old Dominion University, Norfolk, VA. Optical rotations were measured at the
sodium D line (589 nm) on a Rudolph Research Analytical Autopol III polarimeter in reagent
grade solvent.

Experimental Procedures:

5-(4-methoxyphenyl)-5-oxopentanoic acid 113: A mixture of 5.00 g of glutaric
anhydride 11 (0.0438 mol) and 7.11 g anisole 114 (0.0657 mol) was dissolved in 110 mL
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dichloromethane. The resulting solution cooled in to 0°C in an ice-ethanol bath and then 16.6 g
AlCl3 (0.124 moll) was added in portions. The reaction stirred in the ice-ethanol bath and
warmed for 3 hours to room temperature then stirred at room temperature for an additional 15
hours. The reaction mixture was poured into 200 mL of 20% HCl and stirred for 20 minutes. The
crude crystals were collected via vacuum filtration and dried on the filtration apparatus overnight
to give the ketoacid (6.60 g, 68%) as a white solid (m.p. 140-141°C). The product can be
purified further by recrystallization from ethanol. Characterization for this compound was
consistent with that found in the literature.48 TLC: Rf=0.65 (hexanes:EtOAc, 1:1). 1H NMR
(CDCl3, 400 Mz): δ 7.97 (2H, d, J = 8.8 Hz), 6.96 (2H, d, J = 8.8 Hz), 3.88 (3H, s), 3.06 (2H, t, J
= 14.4 Hz), 2.53 (2H, t, J = 14.1 Hz), 2.12 (2H, quint, J = 28.4 Hz).

5-hydroxy-5- (4-methoxyphenyl)valeric acid 42: To a solution of 0.50 g carboxylic
acid 40 (2.25 mol) in 11 mL 5% NaOH was added 0.17 g NaBH4 (4.5 mmol) in portions with
vigorous stirring. After 24 hours an additional 0.08 g NaBH4 (2.25 mmol) was added in portions,
and stirring continued for 24 hours more. The reaction mixture was acidified with 10% HCl and
stirred for 20 minutes. The mixture was extracted with ethyl acetate (5 mL x 3). The organic
layers were dried with MgSO4, filtered, and concentrated in vacuo. The residue was purified via
column chromatography (SiO2; hexanes:EtOAc, 1:1-1:2) to provide alcohol 116 (0.46 g, 92%) as
a colorless oil and lactone 112 (0.02 g, 5%) as a white solid. Characterization for this compound
was consistent with that found in the literature.50 Characterization data for lactone 112 found
below. TLC: Rf = 0.09 (hexanes:EtOAc, 1:1). 1H NMR (CDCl3, 400 Mz) δ 7.25 (2 H, d, J = 4
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Hz), 6.84 (2H, d, J = 4 Hz), 5.29 (1H, t, J = 16 Hz), 3.78 (3H, s), 2.50 (2H, t, J = 16 Hz), 2.00
(4H, m).

6-(4-methoxyphenyl)tetrahydro-2H-pyran-2-one 39: Alcohol 116 (0.20 g, 0.89 mmol)
was combined with triethylamine (0.13 mL, 1.0 mmol) and placed in an ice salt bath and diluted
with 4.8 mL THF. The mixture stirred for 10 minutes, then isobutyl chloroformate 43 (0.1 mL,
1.0 mmol) in 0.5 mL THF was added turning the mixture cloudy and stirred for an additional 10
minutes. The mixture was removed from the bath and stirred at room temperature for 90 minutes.
The mixture was concentrated in vacuo, then 5 mL diethyl ether was added. The mixture was
washed with distilled water (5 mL x 3x). The organic layer was dried with MgSO4, filtered, and
concentrated in vacuo. The residue was purified via column chromatography (SiO2;
hexanes:EtOAc, 2:1-1:2) to provide lactone 112 (0.17 g, 98%) as a white solid (m.p. 61-63°C).
TLC: Rf = 0.39 (hexanes:EtOAc, 1:1). Characterization for this compound was consistent with
that found in the literature. 55 1H NMR (CDCl3, 400 Mz) δ 7.30 (2H, d, J = 6.4 Hz), 6.92 (2H, d, J
= 6 Hz), 5.31 (1H, dd, J = 4.8, 4.4 Hz), 3.82 (3H, s), 2.60 (2H, m), 2.01 (4H, m).
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Dimethyltitanocene (Petasis reagent) 119: Titanocene dichloride 118 (1 g, 4.02 mmol)
was dissolved in 18 mL diethyl ether and cooled to 0°C. Methyllithium (6 mL, 10.04 mmol, 1.6
M in Et2O), was slowly added, turning the reaction bright orange. The reaction stirred for 90
minutes then the septum was removed and 20 mL distilled water was added. The organic layer
was washed with distilled water (10 mL x 3x), dried with MgSO4, filtered, and concentrated in
vacuo to almost dryness. The orange solids were dissolved in 8 mL THF to prepare a solution of
0.5 M.

Exocyclic enol ether 110: Lactone 112 (0.1 g, 0.51 mmol) was dissolved in Petasis
reagent solution 119 (8 mL, 4 mmol, 0.5 M in THF). The apparatus and flask were tented with
aluminum foil and heated to reflux. The mixture stirred at reflux for 25 hours then cooled to
room temperature. The mixture was concentrated in vacuo then 30 mL hexanes was added. The
mixture sat in the freezer overnight, filtered through celite, and concentrated in vacuo. The
process was repeated two more times, adding 5 mL hexanes the second time then 0.5 mL
hexanes the third time. The crude product was isolated as a yellow oil (0.024 g, 23%) and used
without further purification. TLC: Rf = 0.56 (hexanes:EtOAc, 10:1). 1H NMR (CDCl3, 400 Mz) δ
7.32 (2H, d, J = 8.8 Hz), 6.94 (2H, d, J = 8.4 Hz), 4.58 (1H, dd, J = 2.4, 2.4 Hz), 3.81 (3H, s),
2.28 (2H, m), 1.88 (4H, m).
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4-acetoxybenzaldehyde 111: Triethylamine (0.6 mL, 4.09 mmol) and 4hydroxybenzaldehyde 124 (0.5 g, 4.09 mmol) were dissolved in 12.3 mL dichloromethane and
cooled to 0°C. Acyl chloride (0.3 mL, 4.09 mmol) was added dropwise and stirred for 40
minutes. The mixture was washed with 20 mL of sodium bicarbonate and the aqueous layer was
extracted with dichloromethane (10 mL x 3x). The organic layers were dried with MgSO4,
filtered, and concentrated in vacuo. The residue was purified through a silica plug
(hexanes:EtOAc, 4:1) to provide aldehyde 111 (0.55 g, 98%) as a tan liquid. Characterization for
this compound was consistent with that found in the literature. 56 TLC: Rf = 0.59
(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 400 Mz) δ 9.97 (1H, s), 7.90 (2H, d, J = 8.4 Hz), 7.26
(2H, d, J = 8.8 Hz), 2.32 (3H, s).

Alcohol 36: Exocyclic enol ether 110 (0.024 g, 0.117 mmol) and 4-acetoxybenzaldehyde
111 (0.013 g, 0.097 mmol) were combined in 0.2 mL THF. Freshly prepared ZnCl2 solution
(0.01 mL, 0.005 mmol, 0.5 M in THF) was added dropwise. The mixture stirred at room
temperature for 25 hours then one drop of triethylamine was added. The mixture was
concentrated in vacuo. The residue was purified via column chromatography (SiO2;
hexanes:EtOAc 5% Et3N, 4:1) TLC: Rf = 0.31 (hexanes:EtOAc, 2:1).
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